$5.18 Billion is the total value of UBS OCONNOR LLC's 393 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALBANY Mnote2 | $25,913,000,000 | +9.6% | 20,000,000 | 0.0% | 0.50% | +42.0% | ||
| AEGERIONnote2 | $21,579,000,000 | +7.7% | 30,500,000 | 0.0% | 0.42% | +39.9% | ||
| LEXICONnote5 | $21,586,000,000 | -20.4% | 12,000,000 | 0.0% | 0.42% | +3.5% | ||
| CPAAU | CONYERSunit9 | $10,850,000,000 | +0.9% | 1,000,000 | 0.0% | 0.21% | +30.6% | |
| LEN | LENNAR Ccla | $4,051,000,000 | +1.4% | 94,360 | 0.0% | 0.08% | +32.2% | |
| SPWH | SPORTSMA | $3,286,000,000 | -10.8% | 350,000 | 0.0% | 0.06% | +14.5% | |
| TNK | TEEKAY Tcla | $2,507,000,000 | -10.7% | 1,109,403 | 0.0% | 0.05% | +14.3% | |
| TPB | TURNING | $1,802,000,000 | +1.9% | 147,135 | 0.0% | 0.04% | +34.6% | |
| ENDOLOGInote2 | $1,352,000,000 | -6.6% | 1,500,000 | 0.0% | 0.03% | +18.2% | ||
| SALESFORnote0 | $1,167,000,000 | -2.6% | 1,000,000 | 0.0% | 0.02% | +27.8% | ||
| CITRIX Snote0 | $1,162,000,000 | +2.3% | 1,000,000 | 0.0% | 0.02% | +29.4% | ||
| BIOMARINnote0 | $1,123,000,000 | -6.7% | 1,000,000 | 0.0% | 0.02% | +22.2% | ||
| LIBERTYnote1 | $1,079,000,000 | +3.0% | 1,000,000 | 0.0% | 0.02% | +31.2% | ||
| PRICELINnote0 | $1,059,000,000 | -1.6% | 1,000,000 | 0.0% | 0.02% | +25.0% | ||
| AKAMAI Tdbcv2 | $1,040,000,000 | +6.2% | 1,000,000 | 0.0% | 0.02% | +33.3% | ||
| JAZZ INVnote1 | $963,000,000 | -5.5% | 1,000,000 | 0.0% | 0.02% | +26.7% | ||
| ILLUMINAnote6 | $959,000,000 | -7.8% | 1,000,000 | 0.0% | 0.02% | +26.7% | ||
| TWITTERnote0 | $940,000,000 | -2.6% | 1,000,000 | 0.0% | 0.02% | +28.6% | ||
| IMPAX LAnote2 | $794,000,000 | -10.0% | 1,000,000 | 0.0% | 0.02% | +15.4% | ||
| GCVRZ | SANOFIright | $470,000,000 | +40.7% | 1,238,077 | 0.0% | 0.01% | +80.0% | |
| GM | GENERALcall | $252,000,000 | +23.5% | 14,727 | 0.0% | 0.01% | +66.7% | |
| CYHHZ | COMMUNITright | $23,000,000 | -50.0% | 5,055,677 | 0.0% | 0.00% | -100.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| META PLATF | 36 | Q3 2023 | 2.3% |
| SPDR S&P 5 | 33 | Q3 2023 | 0.7% |
| ACTIVISION | 29 | Q3 2023 | 71.3% |
| AMAZON COM | 29 | Q3 2023 | 0.8% |
| GAMING & L | 29 | Q3 2023 | 0.8% |
| SPDR S&P | 29 | Q1 2023 | 0.1% |
| DISNEY W | 28 | Q3 2021 | 2.0% |
| POST HLD | 27 | Q2 2020 | 1.8% |
| GENERAL | 27 | Q3 2022 | 1.4% |
| CAMDEN PPT | 27 | Q3 2023 | 0.6% |
View UBS OCONNOR LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/Sold out | February 13, 2023 | 0 | 0.0% |
| MAGELLAN HEALTH INCSold out | February 13, 2023 | 0 | 0.0% |
| New Providence Acquisition Corp. II | February 13, 2023 | 2,227,500 | 8.9% |
| Nuance Communications, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
| SCP & CO Healthcare Acquisition CoSold out | February 13, 2023 | 0 | 0.0% |
| ACORDA THERAPEUTICS INCSold out | February 14, 2022 | 0 | 0.0% |
| Amryt Pharma plc | February 14, 2022 | 9,950,000 | 3.1% |
| Evolv Technologies Holdings, Inc. | February 14, 2022 | 1,547,311 | 1.1% |
| GreenSky, Inc. | February 14, 2022 | 698,553 | 0.8% |
| GTY Technology Holdings Inc. | February 14, 2022 | 758,000 | 1.3% |
View UBS OCONNOR LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR/A | 2024-02-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
| SC 13G/A | 2024-02-12 |
View UBS OCONNOR LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.